Performance evaluation of predictive models for detecting MMR gene mutations associated with Lynch syndrome in cancer patients in a Chinese cohort in Taiwan

被引:0
|
作者
Hung, Fei-Hung [1 ]
Peng, Hung-Pin [2 ]
Hung, Chen-Fang [3 ]
Hsieh, Ling-Ling [4 ]
Yang, An-Suei [5 ]
Wang, Yong Alison [4 ,6 ]
机构
[1] Taipei Med Univ, Hlth Data Analyt & Stat Ctr, Off Data Sci, Taipei, Taiwan
[2] Acad Sinica, Biomed Translat Res Ctr, Taipei, Taiwan
[3] Koo Fdn Sun Yat Sen Canc Ctr, Dept Res, Taipei, Taiwan
[4] Koo Fdn Sun Yat Sen Canc Ctr, Dept Internal Med, 125 Lih Der Rd, Taipei 11259, Taiwan
[5] Acad Sinica, Genom Res Ctr, Taipei, Taiwan
[6] Natl Yang Ming Chiao Tung Univ, Sch Med, Taipei, Taiwan
关键词
cancer risk management; genetic counseling; Lynch syndrome; MMR mutation risk prediction; NONPOLYPOSIS COLORECTAL-CANCER; INTERNATIONAL-COLLABORATIVE-GROUP; MISMATCH-REPAIR GENES; GERMLINE MUTATIONS; ENDOMETRIAL CANCER; CLINICAL-CRITERIA; PREMM5; MODEL; IDENTIFICATION; HNPCC; RISK;
D O I
10.1002/ijc.35106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Identifying Lynch syndrome significantly impacts cancer risk management, treatment, and prognosis. Validation of mutation risk predictive models for mismatch repair (MMR) genes is crucial for guiding genetic counseling and testing, particularly in the understudied Asian population. We evaluated the performance of four MMR mutation risk predictive models in a Chinese cohort of 604 patients with colorectal cancer (CRC), endometrial cancer (EC), or ovarian cancer (OC) in Taiwan. All patients underwent germline genetic testing and 36 (6.0%) carried a mutation in the MMR genes (MLH1, MSH2, MSH6, and PMS2). All models demonstrated good performance, with area under the receiver operating characteristic curves comparable to Western cohorts: PREMM5 0.80 (95% confidence interval [CI], 0.73-0.88), MMRPro 0.88 (95% CI, 0.82-0.94), MMRPredict 0.82 (95% CI, 0.74-0.90), and Myriad 0.76 (95% CI, 0.67-0.84). Notably, MMRPro exhibited exceptional performance across all subgroups regardless of family history (FH+ 0.88, FH- 0.83), cancer type (CRC 0.84, EC 0.85, OC 1.00), or sex (male 0.83, female 0.90). PREMM5 and MMRPredict had good accuracy in the FH+ subgroup (0.85 and 0.82, respectively) and in CRC patients (0.76 and 0.82, respectively). Using the ratio of observed and predicted mutation rates, MMRPro and PREMM5 had good overall fit, while MMRPredict and Myriad overestimated mutation rates. Risk threshold settings in different models led to different positive predictive values. We suggest a lower threshold (5%) for recommending genetic testing when using MMRPro, and a higher threshold (20%) when using PREMM5 and MMRPredict. Our findings have important implications for personalized mutation risk assessment and counseling on genetic testing.
引用
收藏
页码:2201 / 2210
页数:10
相关论文
共 48 条
  • [31] Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients
    Nan-Yan Rao
    Zhen Hu
    Jin-Ming Yu
    Wen-Feng Li
    Bin Zhang
    Feng-Xi Su
    Jiong Wu
    Zhen-Zhou Shen
    Wei Huang
    Zhi-Ming Shao
    Breast Cancer Research and Treatment, 2009, 116 : 563 - 570
  • [32] Evaluating the performance of models for predicting the BRCA germline mutations in Han Chinese familial breast cancer patients
    Rao, Nan-Yan
    Hu, Zhen
    Yu, Jin-Ming
    Li, Wen-Feng
    Zhang, Bin
    Su, Feng-Xi
    Wu, Jiong
    Shen, Zhen-Zhou
    Huang, Wei
    Shao, Zhi-Ming
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (03) : 563 - 570
  • [33] LYNCH-LIKE SYNDROME MAY BE MORE COMMON IN CHINESE MMRD COLORECTAL CANCER PATIENTS - A COHORT STUDY IN A CHINESE TERTIARY-REFERRAL CENTER.
    Xu, H.
    Zhu, P.
    Zheng, Y.
    Zhang, X.
    Chen, Y.
    Qiao, L.
    Zhang, Y.
    Jiang, F.
    Li, Y.
    Chen, H.
    Chen, Y.
    Gu, Y.
    Yang, B.
    DISEASES OF THE COLON & RECTUM, 2020, 63 (06) : E274 - E275
  • [34] High Probability of Lynch Syndrome Among Colorectal Cancer Patients Is Associated With Higher Occurrence of KRAS and PIK3CA Mutations
    Heriyanto, Didik Setyo
    Yoshuantari, Naomi
    Akbariani, Gilang
    Lau, Vincent
    Hanini, Hanifa
    Hidayati, Zulfa
    Arief, Muhammad Zulfikar
    Gunawan, Andrew Nobiantoro
    Ridwanuloh, Asep Muhamad
    Kusharyoto, Wien
    Handaya, Adeodatus Yuda
    Ilyas, Mohammad
    Kurnianda, Johan
    Hutajulu, Susanna Hilda
    Susanti, Susanti
    WORLD JOURNAL OF ONCOLOGY, 2024, 15 (04) : 612 - 624
  • [35] Predictive factors based on the health belief model on cancer screening behaviour in first degree relatives of patients with Lynch syndrome-associated colorectal cancer
    Gu, Jiaojiao
    Jia, Shumin
    Chao, Huaxiang
    Chen, Tinglan
    Wu, Xiaodan
    INTERNATIONAL JOURNAL OF NURSING SCIENCES, 2023, 10 (02) : 251 - 257
  • [36] Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study
    Wenhui Li
    Di Shao
    Lei Li
    Ming Wu
    Shuiqing Ma
    Xianjie Tan
    Sen Zhong
    Fengming Guo
    Zhe Wang
    Mingzhi Ye
    Journal of Ovarian Research, 12
  • [37] Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort study
    Li, Wenhui
    Shao, Di
    Li, Lei
    Wu, Ming
    Ma, Shuiqing
    Tan, Xianjie
    Zhong, Sen
    Guo, Fengming
    Wang, Zhe
    Ye, Mingzhi
    JOURNAL OF OVARIAN RESEARCH, 2019, 12 (01)
  • [38] Adjunctive Chinese Herbal Medicine Treatment is Associated With an Improved Survival Rate in Patients With Cervical Cancer in Taiwan: A Matched Cohort Study
    Wang, Chieh
    Lin, Kent Yu-Hsien
    Wu, Mei-Yao
    Lin, Cheng-Li
    Lin, Jaung-Geng
    Chang, Cherry Yin-Yi
    Lin, Wu-Chou
    Yen, Hung-Rong
    INTEGRATIVE CANCER THERAPIES, 2021, 20
  • [39] Next-Generation Sequencing Guided the Gene Mutations Associated with mTOR-Inhibitors in Chinese Lung Cancer Patients
    Wu, L.
    Wang, D.
    He, Q.
    Zhang, D.
    Xia, L.
    Zhu, H.
    Huang, J.
    Wang, C.
    Ma, T.
    Zhang, X.
    JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S678 - S679
  • [40] CYP17 and tumor necrosis factor-α gene polymorphisms are associated with risk of oral cancer in Chinese patients in Taiwan
    Chen, WC
    Tsai, MH
    Lei, W
    Chen, WC
    Tsai, CH
    Tsai, FJ
    ACTA OTO-LARYNGOLOGICA, 2005, 125 (01) : 96 - 99